The Cancer Drug Development Forum (CDDF) has announced a joint workshop with the European Organisation for Research and Treatment of Cancer (EORTC) focused on Health Technology Assessment (HTA) in cancer drug development. Scheduled for October 5-6, 2026, in Brussels, the event will gather experts to discuss HTA’s role in oncology through four dedicated sessions. Key topics will include the current HTA landscape, practical implementation challenges, methodological foundations, and future innovations. Registration details will be available soon.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://oncodaily.com/voices/cddf-481772
